retatrutide triple agonist gip glp-1 glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% New obesity drugs are coming,

There is controversy as to whether the intake of L-carnitine can increase the level of L-carnitine in metabolism where it is needed

Also, be sure to check with your health care provider before starting any new regimen like carnitine supplements

Rapamycin and geroprotection: why it remains in the promising category [A: 25:45, V: 26:50]

The potential interactors were subjected to BLAST ( analyses for identification and confirmation of the correct orientation of the insert sequences

54 Oral glutamine, for example, has been proposed to have a useful role in increasing host GSH concentrations in the gut, liver, lung, kidneys, heart, and muscle after exposure to radiation or chemotherapy without enhancing tumor growth

Inflammatory cytokines like TNF-alpha and IL-6 interfere with insulin signaling and promote fat accumulation